McCoy, brought in from Johnson & Johnson to fix troubled Avon in 2012, will cut $400 million in costs by 2016 in hopes of reversing two years of losses and a stock down by a third in the past 12 months. A positive: The company is nearing resolution of a Foreign Corrupt Practices Act investigation that has plagued it since 2008.